HUTCHMED (China) Limited (HCM)
 NASDAQ: HCM · Real-Time Price · USD
 15.31
 +0.63 (4.29%)
  Nov 3, 2025, 4:00 PM EST - Market closed
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HUTCHMED (China) stock has a target of 13.75, which predicts a -10.19% decrease from the current stock price of 15.31.
Price Target: $13.75 (-10.19%)
Analyst Consensus: Sell
* Price targets were last updated on Sep 22, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for HUTCHMED (China) is "Sell". This means that the analyst believes this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | 
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 | 
| Buy | 1 | 1 | 1 | 1 | 0 | 0 | 
| Hold | 1 | 1 | 1 | 1 | 0 | 0 | 
| Sell | 0 | 0 | 0 | 0 | 1 | 1 | 
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 | 
| Total | 3 | 3 | 3 | 3 | 1 | 1 | 
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date | 
|---|---|---|---|---|---|---|---|
|   Morgan Stanley   | Morgan Stanley | Hold → Sell  Downgrades  $18 → $14  | Hold → Sell | Downgrades | $18 → $14 | -10.19% | Sep 22, 2025 | 
|   Goldman Sachs   | Goldman Sachs | Hold  Maintains  $17 → $19  | Hold | Maintains | $17 → $19 | +24.10% | Aug 1, 2024 | 
|   Deutsche Bank   | Deutsche Bank | Hold → Strong Buy  Upgrades  $20 → $22  | Hold → Strong Buy | Upgrades | $20 → $22 | +44.35% | Nov 24, 2023 | 
|   Goldman Sachs   | Goldman Sachs | Hold  Maintains  $15 → $17  | Hold | Maintains | $15 → $17 | +11.04% | Nov 10, 2023 | 
|   Cantor Fitzgerald   | Cantor Fitzgerald | Buy  Reiterates  $50  | Buy | Reiterates | $50 | +226.58% | Sep 5, 2023 | 
Financial Forecast
Revenue This Year
 612.01M 
 from 630.20M
 Decreased by -2.89%
Revenue Next Year
 706.80M 
 from 612.01M
 Increased by 15.49%
EPS This Year
 0.51 
 from 0.04
 Increased by 1,170.74%
EPS Next Year
 0.09 
 from 0.51
 Decreased by -81.62%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 
|---|---|---|---|---|---|
| High | 692.7M | 863.0M | |||
| Avg | 612.0M | 706.8M | |||
| Low | 522.3M | 586.0M | 
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 
|---|---|---|---|---|---|
| High | 9.9%  | 41.0%  | |||
| Avg | -2.9%  | 15.5%  | |||
| Low | -17.1%  | -4.2%  | 
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 
|---|---|---|---|---|
| High | 0.65 | 0.21 | ||
| Avg | 0.51 | 0.09 | ||
| Low | 0.41 | 0.02 | 
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 
|---|---|---|---|---|
| High | 1,527.5%  | -58.7%  | ||
| Avg | 1,170.7%  | -81.6%  | ||
| Low | 922.1%  | -96.1%  | 
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.